Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension

Transplantation. 2004 Jun 15;77(11):1775-6. doi: 10.1097/01.tp.0000122420.86904.89.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Antihypertensive Agents / administration & dosage*
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Humans
  • Hypertension, Portal / complications
  • Hypertension, Portal / drug therapy*
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy*
  • Male
  • Sulfonamides / administration & dosage*

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Sulfonamides
  • Bosentan